Global Trust Asset Management’s GSK GSK Stock Holding History

Global Trust Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-220	Closed	-$7.73K	–	437
2022 Q4	$7.73K	Hold	220	–	–	﹤0.01%	319
2022 Q3	$6K	Hold	220	–	–	﹤0.01%	347
2022 Q2	$12K	Hold	220	–	–	0.01%	310
2022 Q1	$12K	Sell	220 -3,120	-93%	-$169K	0.01%	366
2021 Q4	$184K	Buy	3,340 +2,836	+563%	+$148K	0.07%	184
2021 Q3	$24K	Hold	504	–	–	0.01%	283
2021 Q2	$25K	Hold	504	–	–	0.01%	282
2021 Q1	$22K	Sell	504 -4,046	-89%	-$184K	0.01%	259
2020 Q4	$209K	Sell	4,550 -305	-6%	-$14K	0.11%	164
2020 Q3	$225K	Hold	4,855	–	–	0.14%	138
2020 Q2	$248K	Hold	4,855	–	–	0.17%	122
2020 Q1	$228K	Sell	4,855 -240	-5%	-$12.8K	0.18%	130
2019 Q4	$299K	Hold	5,095	–	–	0.18%	130
2019 Q3	$272K	Sell	5,095 -13,576	-73%	-$698K	0.18%	125
2019 Q2	$272K	Buy	18,671 +13,576	+266%	+$681K	0.18%	127
2019 Q1	$266K	Sell	5,095 -48	-0.9%	-$2.4K	0.2%	124
2018 Q4	$246K	Buy	5,143 +1	+0%	+$49	0.22%	108
2018 Q3	$258K	Sell	5,142 -319	-6%	-$16.2K	0.18%	127
2018 Q2	$275K	Sell	5,461 -32	-0.6%	-$1.61K	0.21%	113
2018 Q1	$268K	Sell	5,493 -84	-2%	-$3.91K	0.21%	112
2017 Q4	$247K	Buy	+5,577	New	+$258K	0.18%	130

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Global Trust Asset Management's GSK Position: Q1 2023 in Review

Global Trust Asset Management sold out of GSK (GSK) in Q1 2023, closing a stake of 220 shares — an estimated $7.73K sold.

Global Trust Asset Management first reported a position in GSK in Q4 2017 and held it in 21 quarters. The position peaked at $299K in Q4 2019. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

Global Trust Asset Management reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
Global Trust Asset Management sold 220 GSK shares in Q1 2023, an estimated $7.73K.
Global Trust Asset Management first reported a position in GSK in Q4 2017 and held it in 21 quarters.
Global Trust Asset Management's GSK position peaked at $299K in Q4 2019.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Global Trust Asset Management's 13F filing for Q1 2023, filed 14 Apr 2023.